Emblem Corp. (EMC.V) (EMMBF), one of Canada’s leading federally-licensed cannabis producers, is pleased to announce the appointment of Nick Dean as the Company’s new Chief Executive Officer effective no later than January 15, 2018, subject to TSX Venture Exchange approval. Mr. Dean succeeds Gordon H. Fox, who has been with the Company since its inception.
The cannabis industry continues to be the hottest sector to invest in as Wall Street has become more favorable on investment opportunities within it.
One of the hottest areas in the cannabis industry has been the Canadian licensed medical cannabis producers which continues to see impressive growth as the number of registered patients has increased at double digit percentages on a month-over-month basis.
Last year, we highlighted Emblem Corp as one of the next big investment opportunities as the company prepared for its initial public offering on the TSX venture exchange.
Yesterday, we reported a major milestone and probably the most significant news in Supreme Pharmaceuticals’ (FIRE.V) (SPRWF) history.
Although we were favorable on this news, we were cautious with the shares due to its market cap being larger than a few of its peers, which are more advanced and larger than Supreme.
Despite the Dow rallying another 220 points and the Nasdaq ending the day above the 6,000, Canadian cannabis stocks were under pressure.
This pressure accelerated throughout the day and followed this tweet from President Trump, “Canada has made business for our dairy farmers in Wisconsin and other border states very difficult. We will not stand for this. Watch!”
Yesterday, legislation to remove cannabis from the Controlled Substances Act and create a federal regulatory process for states to regulate cannabis was introduced in the House of Representatives and Senate.
Canadian cannabis stocks have been under pressure over the last two months and today, the market may have received the catalyst it has so desperately needed…
In early 2015, we highlighted three publicly traded Israeli cannabis companies to watch and we hope you listened!
Although Canadian cannabis stocks have been the story to watch over the last year, Israeli cannabis stocks have been stealing headlines in 2017.
The Canadian cannabis industry has continued to be a bright spot for cannabis investors and 2017 has already provided investors with strong investment returns.
This sub-sector of the cannabis industry has been on fire since July 2016 with the increased interest fueled by the anticipation that Canada will become the first G-7 nation to legalize recreational cannabis.
All Eyes on Legislation this Spring
The global cannabis industry presents investors with the investment opportunities not seen in many years.
The market has never encountered an opportunity like that of the cannabis industry and we expect the industry to witness a growth cycle that is more significant than the technology boom during the 90s.